BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 19926494)

  • 1. Transjugular intrahepatic portosystemic shunt for variceal hemorrhage due to recurrent of hereditary hemorrhagic telangiectasia in a liver transplant.
    Cura MA; Postoak D; Speeg KV; Vasan R
    J Vasc Interv Radiol; 2010 Jan; 21(1):135-9. PubMed ID: 19926494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcome of patients with hereditary hemorrhagic telangiectasia and severe hepatic involvement after orthotopic liver transplantation: a single-center study.
    Dupuis-Girod S; Chesnais AL; Ginon I; Dumortier J; Saurin JC; Finet G; Decullier E; Marion D; Plauchu H; Boillot O
    Liver Transpl; 2010 Mar; 16(3):340-7. PubMed ID: 20209594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
    Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
    Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distal splenorenal shunt: preferred treatment for recurrent variceal hemorrhage in the patient with well-compensated cirrhosis.
    Elwood DR; Pomposelli JJ; Pomfret EA; Lewis WD; Jenkins RL
    Arch Surg; 2006 Apr; 141(4):385-8; discussion 388. PubMed ID: 16618897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver involvement in hereditary hemorrhagic telangiectasia (HHT).
    Garcia-Tsao G
    J Hepatol; 2007 Mar; 46(3):499-507. PubMed ID: 17239481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic vascular malformations in hereditary hemorrhagic telangiectasia.
    Khalid SK; Garcia-Tsao G
    Semin Liver Dis; 2008 Aug; 28(3):247-58. PubMed ID: 18814078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiography of hepatic vascular malformations associated with hereditary hemorrhagic telangiectasia.
    Hashimoto M; Tate E; Nishii T; Watarai J; Shioya T; White RI
    Cardiovasc Intervent Radiol; 2003; 26(2):177-80. PubMed ID: 12813620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver transplantation for hereditary hemorrhagic telangiectasia: Report of the European liver transplant registry.
    Lerut J; Orlando G; Adam R; Sabbà C; Pfitzmann R; Klempnauer J; Belghiti J; Pirenne J; Thevenot T; Hillert C; Brown CM; Gonze D; Karam V; Boillot O;
    Ann Surg; 2006 Dec; 244(6):854-62; discussion 862-4. PubMed ID: 17122610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transjugular intrahepatic portosystemic stent-shunt after orthotopic liver transplantation in a patient with early recurrence of portal hypertension of unknown origin.
    Nolte W; Canelo R; Figulla HR; Kersten J; Sattler B; Münke H; Hartmann H; Ringe B; Ramadori G
    Z Gastroenterol; 1998 Feb; 36(2):159-64. PubMed ID: 9544499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L
    J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transjugular intrahepatic portosystemic shunt versus distal splenorenal shunt--a comparative study.
    Khaitiyar JS; Luthra SK; Prasad N; Ratnakar N; Daruwala DK
    Hepatogastroenterology; 2000; 47(32):492-7. PubMed ID: 10791220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of transjugular intrahepatic portosystemic shunt and surgical portocaval H-shunt for the treatment of colorectal variceal bleeding.
    Uemoto S; Martin AJ; Fleming W; Habib NA
    Hepatogastroenterology; 1995; 42(5):557-60. PubMed ID: 8751215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transjugular placement of an intrahepatic portosystemic shunt as current treatment for complications of portal hypertension].
    Buiskool RA; Pieterman H; van Buuren HR; Laméris JS
    Ned Tijdschr Geneeskd; 1996 Mar; 140(12):659-64. PubMed ID: 8668239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transjugular intrahepatic portosystemic shunts in liver transplant recipients for management of refractory ascites: clinical outcome.
    Saad WE; Darwish WM; Davies MG; Waldman DL
    J Vasc Interv Radiol; 2010 Feb; 21(2):218-23. PubMed ID: 20123207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transjugular intrahepatic portosystemic shunt: efficacy for the treatment of portal hypertension and impact on liver transplantation.
    Cosenza CA; Hoffman AL; Friedman ML; Sher LS; Lopez RR; Van Allen R; Brown DH; Fraiman MH; Arnaout W; Vierling J; Makowka L
    Am Surg; 1996 Oct; 62(10):835-9. PubMed ID: 8813166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of variceal rebleeding and treatment of liver carcinoma by consecutive transjugular intrahepatic portosystemic shunt and hepatic artery chemoembolization.
    Nicolini A; Saccheri S; Lovaria A; Maggi A; Cazzaniga M; Panzeri A; Salerno F
    Ital J Gastroenterol; 1996 Jun; 28(5):269-71. PubMed ID: 8842845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transjugular intrahepatic portosystemic shunts in hemodialysis-dependent patients and patients with advanced renal insufficiency: safety, caution, and encephalopathy.
    Haskal ZJ; Radhakrishnan J
    J Vasc Interv Radiol; 2008 Apr; 19(4):516-20. PubMed ID: 18375295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transjugular intrahepatic portosystemic stent shunt: indications and long-term outcome].
    Wettstein M; Lüthen R; Cohnen M; von Wrisberg F; Mödder U; Häussinger D
    Zentralbl Chir; 2005 Jun; 130(3):246-9. PubMed ID: 15965878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of treatment with transjugular intrahepatic portosystemic shunt or distal splenorenal shunt in the management of variceal bleeding prior to liver transplantation.
    Abouljoud MS; Levy MF; Rees CR; Diamond NG; Lee SP; Mulligan DC; Goldstein RM; Husberg B; Gonwa TA; Klintmalm GB
    Transplantation; 1995 Jan; 59(2):226-9. PubMed ID: 7839445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.